Peregrine Pharmaceuticals (PPHM) Said Internal Review Show Discrepancies Isolated to Placebo

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

Go back to Peregrine Pharmaceuticals (PPHM) Said Internal Review Show Discrepancies Isolated to Placebo

Roth Capital Upgrades Peregrine Pharmaceuticals (PPHM) to Buy

January 7, 2013 8:50 AM EST

Roth Capital upgraded Peregrine Pharmaceuticals (NASDAQ: PPHM) from Neutral to Buy with a price target of $2.70 (from $1.25).

For an analyst ratings summary and ratings history on Peregrine Pharmaceuticals click here. For more ratings news on... More